Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2015 Aug 11;107(9):djv217.
doi: 10.1093/jnci/djv217. Print 2015 Sep.

RE: Breast Cancer Risk After Salpingo-Oophorectomy in Healthy BRCA1/2 Mutation Carriers: Revisiting the Evidence for Risk Reduction

Xinglei Chai  1 , Susan Domchek  1 , Noah Kauff  1 , Timothy Rebbeck  2 , Jinbo Chen  2
Affiliations
Comment

RE: Breast Cancer Risk After Salpingo-Oophorectomy in Healthy BRCA1/2 Mutation Carriers: Revisiting the Evidence for Risk Reduction

Xinglei Chai et al. J Natl Cancer Inst. .
No abstract available

PubMed Disclaimer

Comment in

  • Response.
    Heemskerk-Gerritsen BA, Hooning MJ, Rookus MA; all authors. Heemskerk-Gerritsen BA, et al. J Natl Cancer Inst. 2015 Aug 11;107(9):djv218. doi: 10.1093/jnci/djv218. Print 2015 Sep. J Natl Cancer Inst. 2015. PMID: 26264691 Free PMC article. No abstract available.

Comment on

References

    1. Heemskerk-Gerritsen BA, Seynaeve C, van Asperen CJ, et al. Breast cancer risk after salpingo-oophorectomy in healthy BRCA1/2 mutation carriers: revisiting the evidence for risk reduction. J Natl Cancer Inst. 2015;107 (5):djv033 doi:10.1093/jnci/djv033 - PubMed
    1. Domchek SM, Rebbeck TR. Preventive surgery is associated with reduced cancer risk and mortality in women with BRCA1 and BRCA2 mutations. LDI issue brief. 2010;16 (2):1–4. - PubMed
    1. Kauff N, Domchek S, Friebel T, et al. Risk-Reducing Salpingo-Oophorectomy for the Prevention of BRCA1 and BRCA2 Associated Breast and Gynecologic Cancer: A Multi-Center, Prospective Study. J Clin Oncol. 2008;26 (8):1331–1337. - PMC - PubMed
    1. Wacholder S. Bias in intervention studies that enroll patients from high-risk clinics. J Natl Cancer Inst. 2004;96 (16):1204–1207. - PubMed
    1. Mavaddat N, Peock S, Frost D, et al. Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACE. J Natl Cancer Inst. 2013;105 (11):812–822. - PubMed